ProteinSimple-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ProteinSimple - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014007
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation systems, and western blot imaging systems. Its micro-flow imaging system provides combining of direct imaging capabilities of digital microscopy with the precise control of micro-fluidics. The company’s products are used in protein and antibody characterization, multiplex protein detection, gel and blot imaging; protein aggregation and particle analysis and protein stability and formulation testing applications, among others. ProteinSimple is headquartered in San Jose, California, the US.

ProteinSimple – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProteinSimple, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ProteinSimple, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ProteinSimple, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ProteinSimple, Medical Devices Deals, 2011 to YTD 2017 8
ProteinSimple, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ProteinSimple, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 10
Equity Offering 11
ProteinSimple Withdraws IPO 11
Acquisition 12
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 12
ProteinSimple – Key Competitors 14
ProteinSimple – Key Employees 15
ProteinSimple – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Product News 17
Jan 26, 2016: ProteinSimple Recharges iCE 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
ProteinSimple, Pharmaceuticals & Healthcare, Key Facts 2
ProteinSimple, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
ProteinSimple, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ProteinSimple, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ProteinSimple, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ProteinSimple, Medical Devices Deals, 2011 to YTD 2017 8
ProteinSimple, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 10
ProteinSimple Withdraws IPO 11
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 12
ProteinSimple, Key Competitors 14
ProteinSimple, Key Employees 15
ProteinSimple, Other Locations 16
ProteinSimple, Subsidiaries 16

★海外企業調査レポート[ProteinSimple-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Anadarko Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, …
  • Hitachi Metals, Ltd.:企業の戦略・SWOT・財務分析
    Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Metals, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Euskaltel SA (EKT):企業の財務・戦略的SWOT分析
    Euskaltel SA (EKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Beijer Ref Ab:企業のM&A・事業提携・投資動向
    Beijer Ref Ab - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beijer Ref Ab Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Rift Energy Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Rift Energy Corp (Rift Energy) is an upstream oil and gas exploration and development company that acquires, explores, develops and produces oil and gas assets in east and central Africa. The company's assets include Block L19 in Kenya, which covers approximately 9,000 sq km acres of land in …
  • Sumo Group PLC (SUMO):企業の財務・戦略的SWOT分析
    Sumo Group PLC (SUMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ind-Swift Laboratories Ltd (INDSWFTLAB):企業の財務・戦略的SWOT分析
    Summary Ind-Swift Laboratories Ltd (ISLL) is a manufacturer of active pharmaceutical ingredients and custom chemical products. Its products portfolio includes API’s and finished dosage forms in the therapeutic categories of macrolide antibiotic, antidiabetic, antimigraine, parkinson's disease, antin …
  • PVR Ltd:企業のM&A・事業提携・投資動向
    PVR Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PVR Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Nuri Telecom Co., Ltd. (040160):企業の財務・戦略的SWOT分析
    Nuri Telecom Co., Ltd. (040160) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tenaga Nasional Berhad:戦略・SWOT・企業財務分析
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Healthsense Inc-医療機器分野:企業M&A・提携分析
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Inretail Peru Corp. (INRETC1):企業の財務・戦略的SWOT分析
    Inretail Peru Corp. (INRETC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Adhera Therapeutics (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Australian Gas Networks Ltd-エネルギー分野:企業M&A・提携分析
    Summary Australian Gas Networks Ltd (Australian Gas Networks) formerly Envestra Ltd, is an oil and gas company that distributes and transports natural gas. The company offers services such as managing the haulage of gas through each network, operation and maintenance of gas network, design an constr …
  • Hyatt Hotels Corporation:企業の戦略・SWOT・財務情報
    Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Singareni Collieries Co Ltd:企業の戦略・SWOT・財務情報
    Singareni Collieries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Singareni Collieries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Genentech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • Gol Linhas Aereas Inteligentes SA:企業の戦略・SWOT・財務分析
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆